Skip to main content

Diabetes Device News

Diabetes Devices monitor and help to manage your blood sugar levels to try to stay within the target range, helping prevent complications of diabetes.

BGM    CGM     Injection Pens     Insulin Pumps      AID

All you need to know about diabetic neuropathy - the facts, prevention, and treatment.
Medtronic MiniMed 530G and Enlite CGM – Opening the Door to Closing the Loop.
Newly diagnosed with type 1 diabetes? The top ten things you should know!
On January 20, Tandem announced an expanded recall on its t:slim insulin pump cartridges – the affected cartridges ( listed here ) may be at risk of insulin leaking...
For someone with diabetes, forgetting supplies such as a glucometer or insulin can be a life-threatening risk. HelpAround is a mobile app currently in development that...
On January 10, WellDoc, a clinical and behavioral science company founded by Joslin endocrinologists, announced that it received $20 million of funding, including...
On January 21, Glooko and Joslin announced a partnership to develop a new web/mobile-based diabetes management platform. The system will combine a “Virtual Joslin”...
On January 13, J&J LifeScan announced the launch of the OneTouch VerioSync blood glucose meter in the US. The meter sends blood glucose readings wirelessly (via...
On January 7, the FDA announced updated standards for the accuracy of blood glucose monitors for use in both the home and healthcare facility settings. These standards...
On February 4, Dexcom announced FDA approval of the G4 Platinum CGM for children 2-17 years old in the United States. Dexcom’s G4 Platinum was previously approved in...
The top three things I’d like to see in 2014 – updates on CGM, mHealth, and combination therapy.
My Diabetes Home is an online dashboard that allows patients to record, organize, and track personal diabetes information, including medications, daily blood sugars, A1c...
On November 18, the University of Virginia (UVA) announced that it received a $3.4 million NIH grant for three artificial pancreas studies to be conducted at UVA and...
On December 2, the influential Helmsley Charitable Trust (HCT), one of the world’s largest funders of type 1 diabetes research – and the 12th largest private foundation...
Kelly’s experience in UVA’s overnight closed loop trial makes for fantastic dreams.
The FDA impresses us at The Diabetes Mine Innovation Summit. Plus, sleek new software for downloading data to the cloud.
You call that an artificial pancreas? The pathway to closed loop system.
The three top trends we saw in diabetes in 2013.
The technology giant, Google recently announced that it is working to develop a contact lens that could non-invasively monitor glucose levels from tears. The smart...
Eli Lilly announced in October the submission of dulaglutide, its once-weekly GLP-1 receptor agonist for type 2 diabetes, in the US and Europe. This means a regulatory...

Pages